查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233126

2023-2030 年按类型、配方、分销渠道、产品类型、细分趋势分列的视网膜疾病治疗市场规模、份额和趋势分析报告

Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By Distribution Channel, By Product Type, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

视网膜疾病治疗市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，2023 年至 2030 年全球视网膜疾病治疗市场规模预计将达到 256.9 亿美元，复合年增长率为 9.3%。

市场增长的驱动力是全球视网膜病变的日益流行以及对负担得起的有效治疗的需求未得到满足。此外，增加与眼病相关研发的监管资金预计将进一步推动市场增长。

视网膜疾病是世界人口视力受损的主要原因之一。据世界卫生组织称，到 2022 年，全球将至少有 22 亿人患有近视或远视。其中将近一半（约 10 亿人）的视力问题本可以避免或尚未得到解决。生活方式的改变、预期寿命的延长以及高血压和糖尿病等全身性疾病的流行等因素是视网膜损伤的最常见原因。这表明视网膜疾病患者的治疗需求未得到满足。

年龄相关性黄斑变性 (AMD) 是 65 岁以上人群视力丧失的主要原因之一。AMD 的特征是称为黄斑的视网膜区域退化，该区域负责中央视力。预计不断增长的老年人口将为 AMD 治疗创造更广泛的患者基础。例如，根据 2021 年世界卫生组织的一份报告，到 2030 年，世界上六分之一的人将年满 60 岁。此外，60 岁及以上的人口预计将从 2020 年的 10 亿增长到 14 亿。

与视网膜疾病治疗相关的高成本对市场增长构成威胁。然而，市场上的主要参与者越来越努力开发新产品以加强其产品线，预计将推动市场。例如，2022 年 1 月，Genentech 的 Vabysmo 获得 FDA 批准，成为治疗湿性年龄相关性黄斑变性和糖尿病性黄斑水肿的一流双特异性抗体。新产品的推出预计将推动市场增长。

视网膜疾病治疗市场报告重点

  • 按产品类型划分，黄斑变性部分由于其高患病率、对该病的认识提高以及有前途的管道产品，将在 2022 年占据最大的市场份额。
  • 由于其高渗透率和易用性，预计眼用剂型部分在预测期内将以最快的速度增长。
  • 医院药房在 2022 年将主导分销渠道部分，因为它们易于访问和提供患者记录。
  • 北美将在 2022 年主导全球市场，并且由于视网膜疾病患病率上升和消费者对视网膜疾病的认识不断提高，预计未来将显着增长。
  • 主要参与者包括 Regeneron Pharmaceuticals Inc.、Shire（Takeda Pharmaceutical Company Limited）、Graybug Vision, Inc.、Bayer AG、Santen Pharmaceutical Co., Ltd. 和 Genentech, Inc.。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR内部数据库
    • 次要信息
    • 初步调查
    • 初步调查详情
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法：产品流方法
  • 二级信息列表
  • 缩略语表
  • 目的

2 视网膜疾病治疗市场：执行摘要

  • 市场展望
  • 段快照
  • 竞争格局的快照

3. 视网膜疾病治疗市场变量、趋势和范围

  • 市场系列展望
    • 母市场
  • 流行病学
    • 视网膜疾病
  • 市场动态
    • 市场驱动力分析
      • 目标疾病的患病率增加
      • 强大的管道
      • 老年人口不断增长
      • 提高对视网膜疾病的认识
    • 市场约束因素分析
      • 治疗药物成本高
  • 绘製渗透率和增长前景
  • 视网膜疾病治疗：市场分析工具
    • 行业分析 - 搬运工
    • PESTLE分析
    • 管道分析
    • 重大交易和战略联盟
      • 新产品发布
      • 获得
      • 扩张
      • 合伙
      • 营销和推广

4 视网膜疾病治疗市场：细分分析，按类型，2018-2030 年（百万美元）

  • 定义和范围
  • 类型市场份额分析，2022 年和 2030 年
  • 细分仪表板
  • 全球视网膜疾病治疗市场，按类型，2018-2030
  • 2018-2030年市场规模及预测，趋势分析
    • 黄斑变性
      • 干性黄斑变性
      • 湿性黄斑变性
    • 糖尿病性视网膜病变
    • 其他

5 视网膜疾病治疗市场：细分分析，按配方，2018-2030 年（百万美元）

  • 定义和范围
  • 剂型市场份额分析，2022 年和 2030 年
  • 细分仪表板
  • 全球视网膜疾病治疗市场，按配方，2018-2030
  • 2018-2030年市场规模及预测，趋势分析
    • 凝胶
    • 眼药水和悬液
    • 胶囊/片剂
    • 眼药水
    • 软膏

6 视网膜疾病治疗市场：细分分析，按分销渠道，2018-2030 年（百万美元）

  • 定义和范围
  • 2022 年和 2030 年分销渠道市场份额分析
  • 细分仪表板
  • 全球视网膜疾病治疗市场，按分销渠道，2018-2030 年
  • 2018-2030年市场规模及预测，趋势分析
    • 医院药房
    • 网上药店
    • 零售药店

7 视网膜疾病治疗市场：细分分析，按地区，2018-2030 年（百万美元）

  • 定义和范围
  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场快照
  • SWOT 分析，按因素（政治和法律、经济和技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 多边环境协定
  • 2018-2030 年市场规模、预测和趋势分析
  • 北美
    • 美国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 加拿大
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
  • 欧洲
    • 英国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 德国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 西班牙
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 法国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 意大利
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 挪威
      • 监管框架
      • 竞争情景
      • 投资场景
    • 丹麦
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 瑞典
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
  • 亚太地区
    • 日本
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 中国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 印度
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 韩国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 泰国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 澳大利亚
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
  • 拉丁美洲
    • 巴西
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 墨西哥
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 阿根廷
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
  • 多边环境协定
    • 南非
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 沙特阿拉伯
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景
    • 科威特
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 投资场景

8 视网膜疾病治疗市场——竞争分析

  • 主要市场进入者的最新发展和影响分析
    • 安索夫矩阵
    • 热图分析
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
    • 2022 年主要参与者的市场份额分析
  • 上市公司
    • 公司市场分析
    • 公司各地区市场份额
    • 竞争仪錶盘分析
      • 市场差异化因素
  • 民营企业
    • 主要初创企业名单
  • 公司简介
    • Graybug Vision, Inc.
      • 公司简介
      • 产品基准
      • 战略举措
    • Shire（Takeda Pharmaceutical Company Limited）
      • 公司简介
      • 财务绩效
      • 产品基准
    • Regeneron Pharmaceuticals Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Acucela Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
    • Allergan Plc.（Abbvie Inc.）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Pfizer, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
    • Bayer Ag
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Santen Pharmaceuticals Co. Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Genentech, Inc.（F. Hoffmann-La Roche Ltd.）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Kubota Pharmaceutical Holdings Co., Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-3-68038-766-7

Retinal Disorder Treatment Market Growth & Trends:

The global retinal disorder treatment market size is expected to reach USD 25.69 billion, expanding at a CAGR of 9.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growth in the market is fueled by the increasing prevalence of retinal disorders around the world and the unmet need for affordable and efficient treatments. Furthermore, improved funding by regulatory bodies for R&D associated with ocular disorders is expected to further drive market growth.

Retinal diseases are one of the leading causes of visual impairment among the global population. According to WHO, in 2022, a near or distant vision impairment affects at least 2.2 billion people worldwide. Nearly half of these cases, or around 1 billion, involved vision impairments that either could have been avoided or are still unaddressed. Factors such as changing lifestyles, increased life expectancy, and escalating prevalence of systemic diseases like hypertension and diabetes mellitus are the most common causes of retinal disorders. This demonstrates an unmet need among retinal disorder patients for treatment of the condition.

The rising geriatric population is acting as a driver for the market; age-related macular degeneration (AMD) is one of the leading causes of vision loss in people aged over 65 years. AMD is characterized by the degeneration of an area of the retina known as the macula, which is responsible for central vision. The growing elderly population is expected to create a wider patient pool for the treatment of AMD. For instance, according to a WHO report in 2021, by 2030, 1 in every 6 people in the world will be aged 60 years or over. Furthermore, over this period of time, the population aged over 60 years is expected to increase from 1 billion in 2020 to 1.4 billion.

The high cost associated with retinal disorder treatment poses a threat to the growth of the market. However, increasing efforts from key players operating in the market for developing new products for the enhancement of their product pipeline is expected to drive the market. For instance, in January 2022, Genentech's Vabysmo was approved by the FDA, the first-in-class bispecific antibody for the treatment of wet age-related macular degeneration and diabetic macular edema. The launch of novel products is expected to propel market growth.

Retinal Disorder Treatment Market Report Highlights:

  • By type, the macular degeneration segment held the largest market share in 2022, which is attributable to its high prevalence, rising awareness about the disease, and promising pipeline products
  • Eye drops dosage form segment is projected to grow at the fastest rate over the forecast period due to its high adoption and ease of use
  • Hospital pharmacies held a dominant share of the distribution channel segment in 2022 due to the ease of access and availability of patient records
  • North America dominated the global market in 2022 and is expected to grow considerably in the future, owing to the rising prevalence of retinal disorders and the increasing consumer awareness about retinal disorders
  • A few of the key players include Regeneron Pharmaceuticals Inc., Shire (Takeda Pharmaceutical Company Limited), Graybug Vision, Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., and Genentech, Inc.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Retinal Disorder Treatment Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Retinal Disorder Treatment Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market
  • 3.2 Epidemiology
    • 3.2.1 Retinal Disorders
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers Analysis
      • 3.3.1.1 Increasing Prevalence Of Target Diseases
      • 3.3.1.2 Strong Pipeline
      • 3.3.1.3 Increasing Geriatric Population
      • 3.3.1.4 Rising Awareness Of Retinal Disorders
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High Cost Of Treatment Drugs
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Retinal Disorder Treatment: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
    • 3.5.2 Pestle Analysis
    • 3.5.3 Pipeline Analysis
    • 3.5.4 Major Deals And Strategic Alliances
      • 3.5.4.1 New Product Launch
      • 3.5.4.2 Acquisition
      • 3.5.4.3 Expansion
      • 3.5.4.4 Partnerships
      • 3.5.4.5 Marketing & Promotions

Chapter 4 Retinal Disorder Treatment Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Retinal Disorder Treatment Market, By Type, 2018 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.5.1 Macular Degeneration
      • 4.5.1.1 Macular Degeneration Market, 2018 - 2030 (USD Million)
      • 4.5.1.2 Dry Macular Degeneration
      • 4.5.1.2.1 Dry Macular Degeneration Market, 2018 - 2030 (USD Million)
      • 4.5.1.3 Wet Macular Degeneration
      • 4.5.1.3.1 Wet Macular Degeneration Market, 2018 - 2030 (USD Million)
    • 4.5.2 Diabetic Retinopathy
      • 4.5.2.1 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
    • 4.5.3 Others
      • 4.5.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Retinal Disorder Treatment Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Million)

  • 5.1 Definition And Scope
  • 5.2 Dosage Form Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 To 2030
  • 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 5.5.1 Gels
      • 5.5.1.1 Gels Market, 2018 - 2030 (USD Million)
    • 5.5.2 Eye Solutions & Suspensions
      • 5.5.2.1 Eye Solutions Market, 2018 - 2030 (USD Million)
    • 5.5.3 Capsules & Tablets
      • 5.5.3.1 Capsules & Tablets Market, 2018 - 2030 (USD Million)
    • 5.5.4 Eye Drops
      • 5.5.4.1 Eye Drops Market, 2018 - 2030 (USD Million)
    • 5.5.5 Ointments
      • 5.5.5.1 Ointments Market, 2018 - 2030 (USD Million)

Chapter 6 Retinal Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Definition And Scope
  • 6.2 Distribution Channel Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 To 2030
  • 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
    • 6.5.2 Online Pharmacy
      • 6.5.2.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
    • 6.5.3 Retail Pharmacy
      • 6.5.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Retinal Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2018 To 2030
  • 7.7 North America
    • 7.7.1 North America Retinal Disorder Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.7.2.2 Key Country Dynamics
      • 7.7.2.3 Regulatory Framework
      • 7.7.2.4 Competitive Scenario
      • 7.7.2.5 Investments Scenario
    • 7.7.3 Canada
      • 7.7.3.1 Canada Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.7.3.2 Key Country Dynamics
      • 7.7.3.3 Regulatory Framework
      • 7.7.3.4 Competitive Scenario
      • 7.7.3.5 Investments Scenario
  • 7.8 Europe
    • 7.8.1 Europe Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.8.2 Uk
      • 7.8.2.1 Uk Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.2.2 Key Country Dynamics
      • 7.8.2.3 Regulatory Framework
      • 7.8.2.4 Competitive Scenario
      • 7.8.2.5 Investments Scenario
    • 7.8.3 Germany
      • 7.8.3.1 Germany Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.3.2 Key Country Dynamics
      • 7.8.3.3 Regulatory Framework
      • 7.8.3.4 Competitive Scenario
      • 7.8.3.5 Investments Scenario
    • 7.8.4 Spain
      • 7.8.4.1 Spain Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.4.2 Key Country Dynamics
      • 7.8.4.3 Regulatory Framework
      • 7.8.4.4 Competitive Scenario
      • 7.8.4.5 Investments Scenario
    • 7.8.5 France
      • 7.8.5.1 France Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.5.2 Key Country Dynamics
      • 7.8.5.3 Regulatory Framework
      • 7.8.5.4 Competitive Scenario
      • 7.8.5.5 Investments Scenario
    • 7.8.6 Italy
      • 7.8.6.1 Italy Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.6.2 Key Country Dynamics
      • 7.8.6.3 Regulatory Framework
      • 7.8.6.4 Competitive Scenario
      • 7.8.6.5 Investments Scenario
    • 7.8.7 Norway
      • 7.8.7.1 Norway Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.7.3 Regulatory Framework
      • 7.8.7.4 Competitive Scenario
      • 7.8.7.5 Investments Scenario
    • 7.8.8 Denmark
      • 7.8.8.1 Denmark Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.8.2 Key Country Dynamics
      • 7.8.8.3 Regulatory Framework
      • 7.8.8.4 Competitive Scenario
      • 7.8.8.5 Investments Scenario
    • 7.8.9 Sweden
      • 7.8.9.1 Sweden Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.9.2 Key Country Dynamics
      • 7.8.9.3 Regulatory Framework
      • 7.8.9.4 Competitive Scenario
      • 7.8.9.5 Investments Scenario
  • 7.9 Asia Pacific
    • 7.9.1 Asia-Pacific Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.2.2 Key Country Dynamics
      • 7.9.2.3 Regulatory Framework
      • 7.9.2.4 Competitive Scenario
      • 7.9.2.5 Investments Scenario
    • 7.9.3 China
      • 7.9.3.1 China Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.3.2 Key Country Dynamics
      • 7.9.3.3 Regulatory Framework
      • 7.9.3.4 Competitive Scenario
      • 7.9.3.5 Investments Scenario
    • 7.9.4 India
      • 7.9.4.1 India Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.4.2 Key Country Dynamics
      • 7.9.4.3 Regulatory Framework
      • 7.9.4.4 Competitive Scenario
      • 7.9.4.5 Investments Scenario
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.5.2 Key Country Dynamics
      • 7.9.5.3 Regulatory Framework
      • 7.9.5.4 Competitive Scenario
      • 7.9.5.5 Investments Scenario
    • 7.9.6 Thailand
      • 7.9.6.1 Thailand Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.6.2 Key Country Dynamics
      • 7.9.6.3 Regulatory Framework
      • 7.9.6.4 Competitive Scenario
      • 7.9.6.5 Investments Scenario
    • 7.9.7 Australia
      • 7.9.7.1 Australia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.7.2 Key Country Dynamics
      • 7.9.7.3 Regulatory Framework
      • 7.9.7.4 Competitive Scenario
      • 7.9.7.5 Investments Scenario
  • 7.10 Latin America
    • 7.10.1 Latin America Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.2.2 Key Country Dynamics
      • 7.10.2.3 Regulatory Framework
      • 7.10.2.4 Competitive Scenario
      • 7.10.2.5 Investments Scenario
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.3.2 Key Country Dynamics
      • 7.10.3.3 Regulatory Framework
      • 7.10.3.4 Competitive Scenario
      • 7.10.3.5 Investments Scenario
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.4.2 Key Country Dynamics
      • 7.10.4.3 Regulatory Framework
      • 7.10.4.4 Competitive Scenario
      • 7.10.4.5 Investments Scenario
  • 7.11 MEA
    • 7.11.1 MEA Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.2.2 Key Country Dynamics
      • 7.11.2.3 Regulatory Framework
      • 7.11.2.4 Competitive Scenario
      • 7.11.2.5 Investments Scenario
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.3.2 Key Country Dynamics
      • 7.11.3.3 Regulatory Framework
      • 7.11.3.4 Competitive Scenario
      • 7.11.3.5 Investments Scenario
    • 7.11.4 UAE
      • 7.11.4.1 UAE Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.4.2 Key Country Dynamics
      • 7.11.4.3 Regulatory Framework
      • 7.11.4.4 Competitive Scenario
      • 7.11.4.5 Investments Scenario
    • 7.11.5 Kuwait
      • 7.11.5.1 Kuwait Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.5.2 Key Country Dynamics
      • 7.11.5.3 Regulatory Framework
      • 7.11.5.4 Competitive Scenario
      • 7.11.5.5 Investments Scenario

Chapter 8 Retinal Disorder Treatment Market - Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 8.1.1 Ansoff Matrix
    • 8.1.2 Heat Map Analysis
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2022
  • 8.4 Public Companies
    • 8.4.1 Company Market Position Analysis
    • 8.4.2 Company Market Share, By Region
    • 8.4.3 Competitive Dashboard Analysis
      • 8.4.3.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
  • 8.6 Company Profiles
    • 8.6.1 Graybug Vision, Inc.
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Product Benchmarking
      • 8.6.1.3 Strategic Initiatives
    • 8.6.2 Shire (Takeda Pharmaceutical Company Limited)
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
    • 8.6.3 Regeneron Pharmaceuticals Inc.
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Strategic Initiatives
    • 8.6.4 Acucela Inc.
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
    • 8.6.5 Allergan Plc. (Abbvie Inc.)
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Financial Performance
      • 8.6.5.3 Product Benchmarking
      • 8.6.5.4 Strategic Initiatives
    • 8.6.6 Pfizer, Inc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
    • 8.6.7 Bayer Ag
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Financial Performance
      • 8.6.7.3 Product Benchmarking
      • 8.6.7.4 Strategic Initiatives
    • 8.6.8 Santen Pharmaceuticals Co. Ltd.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial Performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Strategic Initiatives
    • 8.6.9 Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives
    • 8.6.10 Kubota Pharmaceutical Holdings Co., Ltd.
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Global Retinal Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 Global Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 Global Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 6 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 North America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 11 North America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 15 U.S. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Canada Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 19 Canada Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 24 Europe Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 U.K. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 U.K. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 28 U.K. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Germany Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 32 Germany Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 France Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 France Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 36 France Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Italy Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 40 Italy Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Spain Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 44 Spain Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Denmark Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 48 Denmark Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 Sweden Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 52 Sweden Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 Norway Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 56 Norway Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Japan Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 65 Japan Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 China Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 China Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 69 China Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 India Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 India Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 73 India Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 South Korea Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 77 South Korea Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Thailand Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Thailand Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 81 Thailand Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Australia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Australia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Australia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 85 Australia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Latin America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 88 Latin America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 90 Latin America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Mexico Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 Mexico Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 94 Mexico Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 95 Brazil Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 98 Brazil Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 Argentina Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 102 Argentina Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 103 MEA Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 104 MEA Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 105 MEA Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 107 MEA Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 108 South Africa Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 111 South Africa Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 116 UAE Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Retinal Disorder Treatment Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Retinal Disorder Treatment market: Type outlook and key takeaways
  • Fig. 16 Retinal Disorder Treatment market: Type movement analysis & market share 2022 & 2030
  • Fig. 17 Macular degeneration market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Diabetic retinopathy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Other types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Retinal Disorder Treatment market: Dosage form outlook and key takeaways
  • Fig. 21 Retinal Disorder Treatment market: Dosage form movement analysis & market share 2022 & 2030
  • Fig. 22 Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Capsule and tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Retinal Disorder Treatment market: Distribution channel outlook and key takeaways
  • Fig. 28 Retinal Disorder Treatment market: Distribution channel movement analysis & market share 2022 & 2030
  • Fig. 29 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Outlook, 2022 & 2030
  • Fig. 34 Regional Market Dashboard
  • Fig. 35 Regional Market Place: Key Takeaways
  • Fig. 36 North America, SWOT Analysis
  • Fig. 37 Europe, SWOT Analysis
  • Fig. 38 Asia Pacific, SWOT Analysis
  • Fig. 39 Latin America, SWOT Analysis
  • Fig. 40 MEA, SWOT Analysis
  • Fig. 41 North America
  • Fig. 42 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Europe
  • Fig. 48 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 UK
  • Fig. 50 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany
  • Fig. 52 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France
  • Fig. 54 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy
  • Fig. 56 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Spain
  • Fig. 58 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark
  • Fig. 60 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden
  • Fig. 62 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Japan
  • Fig. 68 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India
  • Fig. 72 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Australia
  • Fig. 74 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America
  • Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil
  • Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Mexico
  • Fig. 84 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina
  • Fig. 86 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 MEA
  • Fig. 88 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa
  • Fig. 90 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia
  • Fig. 92 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 93 UAE
  • Fig. 94 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Strategy Mapping